essen tree bpc-157 Nutraceuticals & Cosmeceuticals | Family Healthcare of Lake Norman BPC-157 – Mark Hyman, MD

Heres where things get interesting

doi: 10.1139/bcb-2020-0253

Researchers believe the peptide may bind to carrier proteins in the blood or exist as part of a larger precursor molecule to extend its functional duration in the body

And although symptoms most commonly develop between the ages of 30 and 60, younger people can also be affected

As opposite, in the extracellular medium, a detectable decrease in the concentrations of these proteins would be less likely due to the absence of the cellular machinery for protein degradation

BPC-157 peptide therapy is still relatively new and considered an experimental compound, so it should be used under the supervision of a healthcare professional